160 related articles for article (PubMed ID: 23680573)
1. Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent mechanism.
Zanos P; Wright SR; Georgiou P; Yoo JH; Ledent C; Hourani SM; Kitchen I; Winsky-Sommerer R; Bailey A
Pharmacol Biochem Behav; 2014 Apr; 119():72-9. PubMed ID: 23680573
[TBL] [Abstract][Full Text] [Related]
2. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.
Carson DS; Hunt GE; Guastella AJ; Barber L; Cornish JL; Arnold JC; Boucher AA; McGregor IS
Addict Biol; 2010 Oct; 15(4):448-63. PubMed ID: 20731630
[TBL] [Abstract][Full Text] [Related]
3. Region-specific up-regulation of oxytocin receptor binding in the brain of mice following chronic nicotine administration.
Zanos P; Georgiou P; Metaxas A; Kitchen I; Winsky-Sommerer R; Bailey A
Neurosci Lett; 2015 Jul; 600():33-7. PubMed ID: 26037668
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in oxytocin receptor binding in forebrain regions: correlations with social interest in brain region- and sex- specific ways.
Dumais KM; Bredewold R; Mayer TE; Veenema AH
Horm Behav; 2013 Sep; 64(4):693-701. PubMed ID: 24055336
[TBL] [Abstract][Full Text] [Related]
6. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
Baracz SJ; Parker LM; Suraev AS; Everett NA; Goodchild AK; McGregor IS; Cornish JL
J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26563756
[TBL] [Abstract][Full Text] [Related]
7. Role of adenosine receptor subtypes in methamphetamine reward and reinforcement.
Kavanagh KA; Schreiner DC; Levis SC; O'Neill CE; Bachtell RK
Neuropharmacology; 2015 Feb; 89():265-73. PubMed ID: 25301277
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin receptor blockade reduces acquisition but not retrieval of taste aversion and blunts responsiveness of amygdala neurons to an aversive stimulus.
Olszewski PK; Waas JR; Brooks LL; Herisson F; Levine AS
Peptides; 2013 Dec; 50():36-41. PubMed ID: 24063812
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia.
Zanos P; Keyworth H; Georgiou P; Hambsch B; Otte DM; Kitchen I; Zimmer A; Bailey A
Eur J Neurosci; 2019 Aug; 50(3):2255-2263. PubMed ID: 30218618
[TBL] [Abstract][Full Text] [Related]
10. A critical role of striatal A2A R-mGlu5 R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine.
Wright SR; Zanos P; Georgiou P; Yoo JH; Ledent C; Hourani SM; Kitchen I; Winsky-Sommerer R; Bailey A
Addict Biol; 2016 Jul; 21(4):811-25. PubMed ID: 25975203
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
12. Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression.
Shin EJ; Nabeshima T; Suh HW; Jhoo WK; Oh KW; Lim YK; Kim DS; Choi KH; Kim HC
Behav Brain Res; 2005 Mar; 158(1):143-57. PubMed ID: 15680202
[TBL] [Abstract][Full Text] [Related]
13. The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: Involvement of dopaminergic, noradrenergic and MOPr systems.
Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Kieffer BL; Laorden ML; Bailey A
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2459-64. PubMed ID: 26475574
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin in the regulation of social behaviours in medial amygdala-lesioned mice via the inhibition of the extracellular signal-regulated kinase signalling pathway.
Wang Y; Zhao S; Wu Z; Feng Y; Zhao C; Zhang C
Clin Exp Pharmacol Physiol; 2015 May; 42(5):465-74. PubMed ID: 25707920
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin increases the density of high affinity alpha(2)-adrenoceptors within the hypothalamus, the amygdala and the nucleus of the solitary tract in ovariectomized rats.
Petersson M; Diaz-Cabiale Z; Angel Narváez J; Fuxe K; Uvnäs-Moberg K
Brain Res; 2005 Jul; 1049(2):234-9. PubMed ID: 15967417
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.
Ferré S; Diamond I; Goldberg SR; Yao L; Hourani SM; Huang ZL; Urade Y; Kitchen I
Prog Neurobiol; 2007 Dec; 83(5):332-47. PubMed ID: 17532111
[TBL] [Abstract][Full Text] [Related]
17. Long-term modulation by postnatal oxytocin of the alpha 2-adrenoceptor agonist binding sites in central autonomic regions and the role of prenatal stress.
Díaz-Cabiale Z; Olausson H; Sohlström A; Agnati LF; Narváez JA; Uvnäs-Moberg K; Fuxe K
J Neuroendocrinol; 2004 Mar; 16(3):183-90. PubMed ID: 15049848
[TBL] [Abstract][Full Text] [Related]
18. Involvement of oxytocin and its receptor in nociceptive modulation in the central nucleus of amygdala of rats.
Han Y; Yu LC
Neurosci Lett; 2009 Apr; 454(1):101-4. PubMed ID: 19429063
[TBL] [Abstract][Full Text] [Related]
19. Environmental enrichment enhances conditioned place preference to ethanol via an oxytocinergic-dependent mechanism in male mice.
Rae M; Zanos P; Georgiou P; Chivers P; Bailey A; Camarini R
Neuropharmacology; 2018 Aug; 138():267-274. PubMed ID: 29908241
[TBL] [Abstract][Full Text] [Related]
20. RGS2 mediates the anxiolytic effect of oxytocin.
Okimoto N; Bosch OJ; Slattery DA; Pflaum K; Matsushita H; Wei FY; Ohmori M; Nishiki T; Ohmori I; Hiramatsu Y; Matsui H; Neumann ID; Tomizawa K
Brain Res; 2012 May; 1453():26-33. PubMed ID: 22459044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
